Apyx Medical Corporation APYX US — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's us — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apyx Medical Corporation's US — revenue?
- Apyx Medical Corporation (APYX) reported US — revenue of $8.11M in Q1 2026.
- How has Apyx Medical Corporation's US — revenue changed year-over-year?
- Apyx Medical Corporation's US — revenue increased by 20.3% year-over-year, from $6.74M to $8.11M.
- What is the long-term trend for Apyx Medical Corporation's US — revenue?
- Over 4 years (2021 to 2025), Apyx Medical Corporation's US — revenue has grown at a 4.1% compound annual growth rate (CAGR), from $32.98M to $38.8M.
- What does US — revenue mean?
- This metric represents the total gross revenue generated from sales of products or services to customers within the United States geographic segment, net of any assessed taxes. It serves as a primary indicator of the company's market penetration and commercial success in its domestic region. Tracking this figure allows investors to evaluate the growth trajectory and demand stability of the core business operations within the US market.